Integrating network pharmacology and experimental verification to explore the pharmacological mechanisms of phlorizin against osteoarthritis
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025
DOI: 10.1007/s00210-024-03324-z ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Yi Yao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-Constructed By the Province and Minis…. Hauptthemen laut MEDLINE: Osteoarthritis, Phlorhizin, Anti-Inflammatory Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: the Guangxi Scientific Research and Technological Development Foundation, the Guangxi Science and Technology Major Project.
Abstract (Originalsprache)
To study the pharmacological effects and mechanisms of phlorizin in the treatment of osteoarthritis (OA) through network pharmacological analysis, molecular docking, and experimental validation. First, we screened out the relevant targets related to phlorizin and OA from the public database. The key targets, biological processes, and signaling pathways of phlorizin against OA were identified by protein-protein interaction (PPI) network, Gene Ontology (GO), and Encyclopedia of Kyoto Genes and Genomes (KEGG) pathway enrichment analysis. Subsequently, molecular docking was performed to predict the binding activity between phlorizin and key targets. Finally, we evaluated the effects of phlorizin on hydrogen peroxide-induced OA in rats and validated its possible mechanism of action based on the findings of the network pharmacology analysis. Network pharmacology revealed a total of 235 cross-targets involved in the treatment of OA. Phlorizin's anti-OA effect was found to be primarily mediated through oxidoreductase activity, with JAK-STAT and NF-κB signaling pathways playing a regulating role, according to pathway enrichment analysis. Phlorizin demonstrated a strong affinity for NF-κB1 targets through molecular docking. Moreover, in vitro experiments demonstrated that phlorizin could enhance intracellular antioxidant enzyme activities with good ROS scavenging ability and significantly reduce the expression of NF-κB1 and inflammatory cytokines. Phlorizin can inhibit the progression of OA. The potential underlying mechanism involves inhibiting the NF-κB pathway to reduce inflammation and promote intracellular antioxidant action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-Constructed By the Province and Ministry, Guangxi Key Laboratory of Regenerative Medicine, Guangxi Engineer…
- Life Sciences Institute, Guangxi Medical University, Nanning, 530021, China.
- School of Materials and Environment, Guangxi Minzu University, Nanning, Guangxi, 53000, PR China.
- Life Sciences Institute, Guangxi Medical University, Nanning, 530021, China. zhengli224@163.com.
- Life Sciences Institute, Guangxi Medical University, Nanning, 530021, China. yinfeiying@yeah.net.
- Life Sciences Institute, Guangxi Medical University, Nanning, 530021, China. tanmanli@stu.gxmu.edu.cn.
Förderung
- the Guangxi Scientific Research and Technological Development Foundation
- the Guangxi Science and Technology Major Project
Zitieren
APA
Yao, Y., Zhong, Q., Zhong, Y., Gao, Z., Zhou, B., Lu, C., Zheng, L., Yin, F., & Tan, M. (2025). Integrating network pharmacology and experimental verification to explore the pharmacological mechanisms of phlorizin against osteoarthritis. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03324-z
Vancouver
Yao Y, Zhong Q, Zhong Y, Gao Z, Zhou B, Lu C, et al. Integrating network pharmacology and experimental verification to explore the pharmacological mechanisms of phlorizin against osteoarthritis. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-024-03324-z
BibTeX
@article{Yao2025,
author = {Yao, Yi and Zhong, Qiuling and Zhong, Yanping and Gao, Zixin and Zhou, Bo and Lu, Chun and Zheng, Li and Yin, Feiying and Tan, Manli},
title = {Integrating network pharmacology and experimental verification to explore the pharmacological mechanisms of phlorizin against osteoarthritis},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
doi = {10.1007/s00210-024-03324-z}
}
EUVIMED